SEC Form 4 · accession 0001179110-18-002926
MEDICINES CO /DE · MDCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sarah J. Schlesinger
Director
Period of report
Feb 22, 2018
Accepted (ET)
Feb 26, 2018 · 9:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001113481
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Call Option (right-to-buy)F1 | $29.83 | Feb 22, 2018 | A | 26,383 | A | — | Feb 22, 2028 | Common Stock | 26,383 | 26,383 | D |
Explanation of responses
- F1This option vests in one installment on February 22, 2021 and is made part of and pursuant to Issuer's director compensation package.